An evaluation of torsemide in patients with heart failure and renal disease

AE Peters, RJ Mentz, TA DeWald… - Expert review of …, 2022 - Taylor & Francis
Introduction Torsemide is a loop diuretic that inhibits the Na+/K+/2Cl− cotransporter type 2 in
the thick ascending loop of Henle, leading to increased excretion of urinary sodium and …
被引用次数：17 相关文章
[HTML] nih.gov

[HTML][HTML] An evaluation of torsemide in patients with heart failure and renal disease

AE Peters, RJ Mentz, TA DeWald… - Expert review of …, 2022 - ncbi.nlm.nih.gov
I. Introduction—Torsemide is a loop diuretic that inhibits the Na+/K+/2Cl− cotransporter type
2 in the thick ascending loop of Henle, leading to increased excretion of urinary sodium and …

An evaluation of torsemide in patients with heart failure and renal disease

AE Peters, RJ Mentz, TA DeWald… - Expert review of …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Torsemide is a loop diuretic that inhibits the Na+/K+/2Cl-cotransporter type 2 in
the thick ascending loop of Henle, leading to increased excretion of urinary sodium and …

An evaluation of torsemide in patients with heart failure and renal disease.

AE Peters, RJ Mentz, TA DeWald… - Expert Review of …, 2022 - europepmc.org
Torsemide is a loop diuretic that inhibits the Na+/K+/2Cl-cotransporter type 2 in the thick
ascending loop of Henle, leading to increased excretion of urinary sodium and chloride and …

An evaluation of torsemide in patients with heart failure and renal disease.

AE Peters, RJ Mentz, TA DeWald… - Expert Review of …, 2022 - europepmc.org
I. Introduction—Torsemide is a loop diuretic that inhibits the Na+/K+/2Cl− cotransporter type
2 in the thick ascending loop of Henle, leading to increased excretion of urinary sodium and …